New tool determines leukemia cells' 'readiness to die,' may guide clinical care
Researchers at Dana-Farber Cancer Institute have developed a novel method for determining how ready acute myeloid leukemia (AML) cells are to die, a discovery that may help cancer specialists to choose treatments option more ...
Cancer
Oct 11, 2012 |
5 / 5 (1) |
0
|
Women respond better to the treatment of lymph gland cancer with antibodies than men
(Medical Xpress)—Women respond much better than men to the treatment of chronic follicular lymphoma with a monoclonal antibody that targets CD20 (rituximab). These are the findings of a multi-centre, Austria-wide ...
Cancer
Oct 10, 2012 |
5 / 5 (1) |
0
Study sheds light on bone marrow stem cell therapy for pancreatic recovery
Researchers at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute have found that a blood vessel-building gene boosts the ability of human bone marrow stem cells to sustain pancreatic recovery in a laboratory mouse model ...
Medical research
Oct 02, 2012 |
not rated yet |
0
Researchers harness the immune system to improve stem cell transplant outcomes
A novel therapy in the early stages of development at Virginia Commonwealth University Massey Cancer Center shows promise in providing lasting protection against the progression of multiple myeloma following a stem cell transplant ...
Immunology
Oct 01, 2012 |
5 / 5 (1) |
0
|
Cryopreservation of induced pluripotent stem cells improved the most by one product
In a study to determine the best cryopreservation (freezing) solution to maintain induced pluripotent stem (iPS) cells, a team of researchers from Japan compared 12 kinds of commercially prepared and readily available cryopreservation ...
Medical research
Sep 25, 2012 |
not rated yet |
0
Bone marrow holds secrets for treating colitis and Crohn's
(Medical Xpress)—Michigan State University researchers have unlocked secrets in bone marrow that could lead to improved treatments for colitis and Crohn's disease.
Medical research
Sep 24, 2012 |
not rated yet |
0
|
'Half-match' bone marrow transplants wipe out sickle cell disease in selected patients
In a preliminary clinical trial, investigators at Johns Hopkins have shown that even partially-matched bone marrow transplants can eliminate sickle cell disease in some patients, ridding them of painful and debilitating symptoms, ...
Medical research
Sep 20, 2012 |
not rated yet |
0
|
Researchers find novel predictor for MDS progression risk
Researchers at Moffitt Cancer Center and colleagues have discovered that changes in the physical characteristics of the effector memory regulatory T cell can predict the progression risk of myelodysplastic syndromes (MDS) ...
Immunology
Sep 13, 2012 |
not rated yet |
0
|
Researchers restore children's immune systems with refinements in gene therapy
Researchers have demonstrated that a refined gene therapy approach safely restores the immune systems of some children with severe combined immunodeficiency (SCID). The rare condition blocks the normal development of a newborn's ...
Immunology
Sep 11, 2012 |
5 / 5 (3) |
0
|
Race, ethnicity affect likelihood of finding suitable unrelated stem cell donor for cancer patients
(Medical Xpress)—Researchers at Moffitt Cancer Center and colleagues have published a study describing the greater difficulty in finding matched, unrelated donors for non-Caucasian patients who are candidates for hematopoietic ...
Cancer
Sep 11, 2012 |
not rated yet |
0
|
Improved diagnostic test benefits children with acute myeloid leukemia
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML). The information can help physicians decide whether a more intensive approach is needed. Research ...
Cancer
Sep 10, 2012 |
not rated yet |
0
FDA approves Pfizer drug for rare blood cancer
Pfizer Inc. says the Food and Drug Administration on Tuesday approved its new drug to treat a rare form of blood and bone marrow cancer.
Medications
Sep 04, 2012 |
not rated yet |
0
New genetic clues to why most bone marrow transplant patients develop graft-versus-host disease
A team of scientists led by a bone marrow transplant researcher at Fred Hutchinson Cancer Research Center has shed new light on why most bone marrow transplant patients who receive tissue-matched cells from unrelated donors ...
Medical research
Sep 04, 2012 |
4 / 5 (1) |
0
|
EU approves Novartis-Incyte blood cancer drug
Novartis AG and Incyte Corp. said Tuesday that European Union regulators approved their blood cancer drug Jakavi.
Medications
Sep 04, 2012 |
not rated yet |
0
Tapping the body to fight disease
Biju Parekkadan saw his future in the plight of a newborn thousands of miles away.
Medical research
Sep 03, 2012 |
not rated yet |
0
